Measured Risk Portfolios Inc. Has $1.65 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Measured Risk Portfolios Inc. lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 8.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 94,228 shares of the real estate investment trust’s stock after acquiring an additional 7,449 shares during the period. Healthpeak Properties makes up approximately 1.6% of Measured Risk Portfolios Inc.’s holdings, making the stock its 29th biggest holding. Measured Risk Portfolios Inc.’s holdings in Healthpeak Properties were worth $1,650,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Invesco Ltd. raised its position in shares of Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after acquiring an additional 3,967,830 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in Healthpeak Properties by 6.5% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust’s stock worth $372,004,000 after purchasing an additional 1,129,924 shares in the last quarter. Centersquare Investment Management LLC increased its stake in Healthpeak Properties by 18.5% during the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust’s stock worth $268,642,000 after purchasing an additional 2,070,416 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Healthpeak Properties by 0.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust’s stock worth $210,126,000 after purchasing an additional 76,978 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Healthpeak Properties by 0.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust’s stock worth $207,012,000 after purchasing an additional 84,551 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DOC has been the subject of a number of research reports. Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Monday, September 15th. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Wells Fargo & Company lowered their target price on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a research note on Saturday, September 27th. Finally, Morgan Stanley decreased their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, August 22nd. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average target price of $21.33.

Healthpeak Properties Price Performance

Shares of DOC opened at $19.39 on Friday. The stock has a market capitalization of $13.47 billion, a P/E ratio of 80.77, a P/E/G ratio of 2.50 and a beta of 1.09. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26. The company has a 50 day moving average of $17.86 and a 200-day moving average of $18.01. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to analysts’ expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business’s quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.3%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties’s dividend payout ratio is presently 508.33%.

Insider Activity at Healthpeak Properties

In related news, CEO Scott M. Brinker acquired 1,490 shares of the business’s stock in a transaction dated Monday, August 4th. The stock was bought at an average price of $16.83 per share, with a total value of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This represents a 0.71% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders purchased 8,783 shares of company stock valued at $150,129. Corporate insiders own 0.23% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.